SELECTing the Best

No AccessJournal of UrologyEditorial1 Feb 2007SELECTing the Bestis companion ofSelenomethionine Induced Transcriptional Programs in Human Prostate Cancer Cells Eric A. Klein Eric A. KleinEric A. Klein More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2006.10.099AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "SELECTing the Best." The Journal of Urology, 177(2), pp. 428–429 References 1 : Selenium: epidemiology and basic science. J Urol2004; 171: S50. Link, Google Scholar 2 : SELECT: the next prostate cancer prevention trial. J Urol2001; 166: 1311. Link, Google Scholar 3 : Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial. JAMA1996; 276: 1957. Google Scholar 4 : Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst2005; 97: 94. Google Scholar 5 : In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res2000; 60: 2882. Google Scholar 6 : New concepts in selenium chemoprevention. Cancer Metastasis Rev2002; 21: 281. Google Scholar Section of Urologic Oncology, Glickman Urologic Institute, Cleveland Clinic Foundation, Cleveland, Ohio© 2007 by American Urological AssociationFiguresReferencesRelatedDetailsRelated articlesJournal of Urology9 Nov 2018Selenomethionine Induced Transcriptional Programs in Human Prostate Cancer Cells Volume 177Issue 2February 2007Page: 428-429 Advertisement Copyright & Permissions© 2007 by American Urological AssociationMetricsAuthor Information Eric A. Klein More articles by this author Expand All Advertisement PDF downloadLoading ...